The coronavirus pandemic offered Teladoc Health (NYSE: TDOC) a significant boost in 2020. Revenue climbed by triple-digit percentages from quarter to quarter, and its share price surged by 138% for the year. The concern was that Teladoc's business would lose a lot of steam as the pandemic waned and patients could comfortably return to doctors' offices.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting